TACE Plus PD-1 Antibody vs TACE Alone for Unresectable HCC

NCT03782831 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No participants enrolled

Conditions

Hepatocellular Carcinoma

Interventions

PROCEDURE: TACE
DRUG: PD-1 antibody
DRUG: Placebos

Sponsor

Sun Yat-sen University

Collaborators

[object Object]
[object Object]